Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Term ID:8909
Name:Phosphoribosylpyrophosphate Synthetase Superactivity
Definition:
Alternative IDs:OMIM:300661
ParentIDs:MESH:D011686
TreeNumbers:C16.320.565.798/C567064 |C18.452.648.798/C567064
Synonyms:Gout, PRPS-Related |PRPS1 SUPERACTIVITY GOUT, PRPS-RELATED, INCLUDED
Slim Mappings:Genetic disease (inborn)|Metabolic disease
Reference: MedGen: C567064
MeSH: C567064
OMIM: 300661;

Genes: PRPS1;
Phenotypes
1 HP:0001419X-linked recessive inheritance
2 HP:0001251Ataxia
3 HP:0001290Generalized hypotonia
4 HP:0001997Gout
5 HP:0003149Hyperuricosuria
6 HP:0001252Hypotonia
7 HP:0001249Intellectual disability
8 HP:0001270Motor delay
9 HP:0000083Renal insufficiency
10 HP:0000407Sensorineural hearing impairment
11 HP:0000791Uric acid nephrolithiasis
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_002764.3(PRPS1):c.154G>C (p.Asp52His)5631PRPS1Pathogenic137852542RCV000010608; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106882556106882556NM_002764.3:c.154G>CNP_002755.1:p.Asp52HisNC_000023.10:g.106882556G>COMIM Allelic Variant:311850.0003C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity
NM_002764.3(PRPS1):c.341A>G (p.Asn114Ser)5631PRPS1Pathogenic137852540RCV000010606; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106884166106884166NM_002764.3:c.341A>GNP_002755.1:p.Asn114SerNC_000023.10:g.106884166A>GOMIM Allelic Variant:311850.0001C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity
NM_002764.3(PRPS1):c.385C>A (p.Leu129Ile)5631PRPS1Pathogenic137852543RCV000010609; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106884210106884210NM_002764.3:c.385C>ANP_002755.1:p.Leu129IleNC_000023.10:g.106884210C>AOMIM Allelic Variant:311850.0005C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity
NM_002764.3(PRPS1):c.547G>C (p.Asp183His)5631PRPS1Pathogenic137852541RCV000010607; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106888423106888423NM_002764.3:c.547G>CNP_002755.1:p.Asp183HisNC_000023.10:g.106888423G>COMIM Allelic Variant:311850.0002C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity
NM_002764.3(PRPS1):c.569C>T (p.Ala190Val)5631PRPS1Pathogenic137852544RCV000010610; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106888445106888445NM_002764.3:c.569C>TNP_002755.1:p.Ala190ValNC_000023.10:g.106888445C>TOMIM Allelic Variant:311850.0007C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity
NM_002764.3(PRPS1):c.579C>G (p.His193Gln)5631PRPS1Pathogenic137852545RCV000010611; NMedGen:C1970827,OMIM:300661,ORPHA:3222X106888455106888455NM_002764.3:c.579C>GNP_002755.1:p.His193GlnNC_000023.10:g.106888455C>GOMIM Allelic Variant:311850.0008C1970827 300661 Phosphoribosylpyrophosphate synthetase superactivity